Here, the immune checkpoint LILRB1 is introduced putting a focus on its role in the regulation of monocytes, macrophages and cytotoxic lymphocytes, and perspectives for LILRB1 targeting in the treatment of cancer are outlined. This evidence concerns the gene LILRB1 and cancer.